Daisuke Noro

Hirosaki, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

Real-world safety and efficacy of enzalutamide versus darolutamide in nonmetastatic castration-resistant prostate cancer: a multicenter retrospective study.

Real-world safety and efficacy of enzalutamide versus darolutamide in nonmetastatic castration-resistant prostate cancer: a multicenter retrospective study.

Journal: ESMO real world data and digital oncology

Published: July 13, 2026

Efficacy, Safety, and Cost-Effectiveness of Reduced versus Full Initial Doses of Androgen Receptor Signaling Inhibitors in Non-Metastatic Castration-Resistant Prostate Cancer: A Multicenter Retrospective Study.

Efficacy, Safety, and Cost-Effectiveness of Reduced versus Full Initial Doses of Androgen Receptor Signaling Inhibitors in Non-Metastatic Castration-Resistant Prostate Cancer: A Multicenter Retrospective Study.

Journal: The Prostate

Published: December 31, 2025

Cross-resistance among novel androgen receptor signaling inhibitors in non-metastatic castration-resistant prostate cancer.

Cross-resistance among novel androgen receptor signaling inhibitors in non-metastatic castration-resistant prostate cancer.

Journal: International journal of clinical oncology

Published: June 20, 2025

Real-world trends in the use and outcomes of novel androgen receptor signaling inhibitor therapy in patients with non-metastatic castration-resistant prostate cancer: a multicenter retrospective study.

Real-world trends in the use and outcomes of novel androgen receptor signaling inhibitor therapy in patients with non-metastatic castration-resistant prostate cancer: a multicenter retrospective study.

Journal: International journal of clinical oncology

Published: April 13, 2025

Treatment trends in patients with de novo metastatic prostate cancer in the era of upfront combination therapy.

Treatment trends in patients with de novo metastatic prostate cancer in the era of upfront combination therapy.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: March 13, 2024

Impact of severe acute kidney injury on short-term mortality in urosepsis.

Impact of severe acute kidney injury on short-term mortality in urosepsis.

Journal: World journal of urology

Published: January 03, 2024

Real-world effects of novel androgen receptor axis-targeted agents on oncological outcomes in non-metastatic castration-resistant prostate cancer: A multi-institutional retrospective study.

Real-world effects of novel androgen receptor axis-targeted agents on oncological outcomes in non-metastatic castration-resistant prostate cancer: A multi-institutional retrospective study.

Journal: Prostate international

Published: August 28, 2023

Utility of the Age Discrepancy between Frailty-Based Biological Age and Expected Life Age in Patients with Urological Cancers.

Utility of the Age Discrepancy between Frailty-Based Biological Age and Expected Life Age in Patients with Urological Cancers.

Journal: Cancers

Published: November 23, 2022

Oncological and functional outcomes of female reproductive organ-sparing radical cystectomy and ileal neobladder construction.

Oncological and functional outcomes of female reproductive organ-sparing radical cystectomy and ileal neobladder construction.

Journal: Urologic oncology

Published: May 29, 2022

Machine learning diagnosis by immunoglobulin N-glycan signatures for precision diagnosis of urological diseases.

Machine learning diagnosis by immunoglobulin N-glycan signatures for precision diagnosis of urological diseases.

Journal: Cancer science

Published: March 18, 2022

Effect of upfront combination therapy on the overall survival of patients with metastatic castration-sensitive prostate cancer: A multicenter retrospective study.

Effect of upfront combination therapy on the overall survival of patients with metastatic castration-sensitive prostate cancer: A multicenter retrospective study.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: February 08, 2022

Prognostic impact of proton pump inhibitors for immunotherapy in advanced urothelial carcinoma.

Prognostic impact of proton pump inhibitors for immunotherapy in advanced urothelial carcinoma.

Journal: BJUI compass

Published: September 18, 2021

Showing 1-12 of 40

Last Updated: 09/26/2026